|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/03/23 Cavitation Technologies, Inc. 10-K 6/30/23 61:4.2M GlobalOne Filings Inc/FA |
Document/Exhibit Description Pages Size
1: 10-K Form 10-K for June 2023 HTML 755K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 20K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 20K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 17K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 17K
11: R1 Cover HTML 80K
12: R2 Consolidated Balance Sheets HTML 115K
13: R3 Consolidated Balance Sheets (Parenthetical) HTML 38K
14: R4 Consolidated Statements of Operations HTML 85K
15: R5 Consolidated Statements of Operations HTML 35K
(Parenthetical)
16: R6 Consolidated Statements of Changes in HTML 71K
Stockholders' Equity (Deficit)
17: R7 Consolidated Statements of Cash Flows HTML 104K
18: R8 Organization and Summary of Significant Accounting HTML 73K
Policies
19: R9 Contracts with Desmet Ballestra HTML 29K
20: R10 Investment in Equity Method Investments HTML 36K
21: R11 Operating Lease HTML 38K
22: R12 Property and Equipment HTML 32K
23: R13 Related Party Transactions HTML 25K
24: R14 Notes Payable HTML 35K
25: R15 Stockholders? Equity (Deficit) HTML 103K
26: R16 Income Taxes HTML 37K
27: R17 Commitments and Contingencies HTML 23K
28: R18 Organization and Summary of Significant Accounting HTML 123K
Policies (Policies)
29: R19 Organization and Summary of Significant Accounting HTML 31K
Policies (Tables)
30: R20 Investment in Equity Method Investments (Tables) HTML 26K
31: R21 Operating Lease (Tables) HTML 38K
32: R22 Property and Equipment (Tables) HTML 30K
33: R23 Notes Payable (Tables) HTML 24K
34: R24 Stockholders? Equity (Deficit) (Tables) HTML 87K
35: R25 Income Taxes (Tables) HTML 34K
36: R26 Organization and Summary of Significant Accounting HTML 29K
Policies (Details- Property and Equipment)
37: R27 Organization and Summary of Significant Accounting HTML 25K
Policies (Details - Antidilutive shares)
38: R28 Organization and Summary of Significant Accounting HTML 76K
Policies (Details Narrative)
39: R29 Contracts with Desmet Ballestra (Details HTML 37K
Narrative)
40: R30 Investment in equity method investment (Details - HTML 56K
Rollforward)
41: R31 Investment in Equity Method Investments (Details HTML 47K
Narrative)
42: R32 Operating Lease (Details - Lease Cost) HTML 35K
43: R33 Operating Lease (Details - Operating Lease Minimum HTML 28K
payments)
44: R34 Property and Equipment (Details) HTML 37K
45: R35 Property and Equipment (Details Narrative) HTML 22K
46: R36 Related Party Transactions (Details Narrative) HTML 20K
47: R37 Notes Payable (Details) HTML 30K
48: R38 Notes Payable (Details Narrative) HTML 49K
49: R39 Stockholders' Deficit (Details - Option activity) HTML 56K
50: R40 Stockholders' Deficit (Details - Warrant activity) HTML 54K
51: R41 Stockholders' Deficit (Details - Warrants by HTML 39K
exercise price)
52: R42 Stockholders' Deficit (Details - Assumptions) HTML 36K
53: R43 Stockholders? Equity (Deficit) (Details Narrative) HTML 81K
54: R44 Income Taxes (Details- Tax Reconciliation) HTML 27K
55: R45 Income Taxes (Details- Deferred Tax Assets and HTML 28K
Liabilities)
56: R46 Income Taxes (Details Narrative) HTML 19K
59: XML IDEA XML File -- Filing Summary XML 106K
57: XML XBRL Instance -- cavitation_i10k-063023_htm XML 752K
58: EXCEL IDEA Workbook of Financial Report Info XLSX 97K
7: EX-101.CAL XBRL Calculations -- cvat-20230630_cal XML 136K
8: EX-101.DEF XBRL Definitions -- cvat-20230630_def XML 337K
9: EX-101.LAB XBRL Labels -- cvat-20230630_lab XML 725K
10: EX-101.PRE XBRL Presentations -- cvat-20230630_pre XML 588K
6: EX-101.SCH XBRL Schema -- cvat-20230630 XSD 111K
60: JSON XBRL Instance as JSON Data -- MetaLinks 355± 516K
61: ZIP XBRL Zipped Folder -- 0001683168-23-006921-xbrl Zip 201K
Exhibit 31.1
Certification
I, N. Voloshin, certify that:
1. I have reviewed this annual report for the fiscal year ended June 30, 2023 on Form 10-K of Cavitation Technologies, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
| Date: October 3, 2023 | /s/ N. VOLOSHIN |
| Name: N. Voloshin | |
| Title: Chief Executive Officer |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 10/3/23 | |||
| For Period end: | 6/30/23 | NT 10-K | ||
| List all Filings | ||||